Details of the Drug
General Information of Drug (ID: DMNGSQK)
| Drug Name |
N*4*-Benzyl-6-chloro-pyrimidine-2,4-diamine
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
91066-67-0; CHEMBL158113; N4-Benzyl-6-chloropyrimidine-2,4-diamine; N~4~-benzyl-6-chloropyrimidine-2,4-diamine; 4-N-benzyl-6-chloropyrimidine-2,4-diamine; N~4~-benzyl-6-chloro-2,4-pyrimidinediamine; 2,4-Pyrimidinediamine, 6-chloro-N4-(phenylmethyl)-; N*4*-Benzyl-6-chloro-pyrimidine-2,4-diamine; Oprea1_700029; AC1Q52S4; AC1LS938; SCHEMBL1319082; CTK6G7145; DTXSID50363293; GXNJAZPAQIPYMJ-UHFFFAOYSA-N; MolPort-001-843-083; KS-00003D1N; ALBB-022867; ZINC1398022; SBB098322; BDBM50022150; AKOS015993366
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 234.68 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 2.6 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||


